Needles in Our Technology Haystacks: Defining Efficacy Is Easy, Characterizing Complications Is the Challenge
Name
nihms915942.pdf
Description
Accepted version
Size
40.1 KB
Format
Adobe PDF
Checksum (MD5)
dea53ed21f3cdff7f5659e522d39f4ae
Author(s)
Edelman, Elazer R
Wang, Pei-Jiang
Date Issued
November 2017
Journal
Circulation: Cardiovascular Interventions
Publisher
Ovid Technologies (Wolters Kluwer Health)
Citation
Edelman, Elazer R. and Pei-Jiang Wang. "Needles in Our Technology Haystacks: Defining Efficacy Is Easy, Characterizing Complications Is the Challenge." Circulation: Cardiovascular Interventions 10, 11 (November 2017): http://dx.doi.org/10.1161/circinterventions.117.006059
Version
Author's final manuscript
Abstract
In this issue of Circulation: Cardiovascular Interventions, Rhee et al address an interesting aspect of technology development—the delineation of device complications in an era of accelerating innovation. They specifically sought to validate longitudinal stent deformation (LSD) as a design-dependent complication, pooling data from several studies using precise definitions, and longer periods of evaluation to overcome what they cite as shortcomings of prior studies.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1161/circinterventions.117.006059
